Abstract:Background: Bacteriotherapy and modulation of intestinal microbiome by administering probiotics, prebiotics, or both have long been suggested to prevent morbidity and mortality in premature infants. Our objective was to assess the comparative effectiveness of different prophylactic strategies in a network meta-analysis (NMA) of randomized trials.Methods: We searched MEDLINE, EMBASE, Science Citation Index Expanded, CINAHL, Scopus, Cochrane Central, BIOSIS Previews, and Google Scholar from inception up until December 1, 2018· All-cause mortality, severe necrotizing enterocolitis (NEC - Bell stage II or more), and culture proven sepsis were our a priori primary outcomes. We used a frequentist approach for NMA and assessed the certainty of evidence using the GRADE approach.Findings: We included 79 trials involving 17,655 preterm infants. Multiple-strain probiotics alone proved the only intervention with moderate- or high-quality evidence of reduced all-cause mortality relative to placebo (OR = 0·67; 95% CI: 0·52, 0·87; high certainty; absolute risk reduction = 1·5%). Compared to placebo, multiple-strain probiotics (OR = 0·35; 95% CI: 0·26, 0·47; moderate certainty; absolute risk reduction = 4·1%), and single-strain probiotics alone (OR = 0·63; 95% CI: 0·46, 0·86; moderate certainty; absolute risk reduction = 2·3%) or in combination with lactoferrin (OR = 0·04; 95% CI: 0·01, 0·62; moderate certainty; absolute risk reduction = 6·2%) were among the interventions with moderate- or high-quality evidence that significantly reduced severe NEC. Among the intervention with moderate- or high-quality evidence relative to placebo, single-strain probiotics combined with lactoferrin (OR = 0·27; 95% CI: 0·10, 0·72; moderate certainty; absolute risk reduction = 11·00%) or alone (OR = 0·80; 95% CI: 0·65, 0·99; moderate certainty; absolute risk reduction = 2·6%) and lactoferrin alone (OR = 0·44; 95% CI: 0·27, 0·74; moderate certainty; absolute risk reduction = 5·1%) demonstrated statistically significant reduction in culture proven late-onset sepsis.Interpretation: Moderate-to-high certainty evidence demonstrates the superiority of single and multi-strain probiotics over alternative preventive treatments. Synbiotics (multiple-strain probiotics in combination with prebiotics) provide the largest reduction in morbidity and mortality in preterm infants but this is supported by only low-to-very low certainty evidence; thus, prioritizing synbiotics in future trials may provide important insights.Funding: Mitacs in partnership with Nestlé Canada.Declaration of Interest: PMS is the recipient of research support provided by Lallemand Human Nutrition Inc. (Montreal, Quebec, Canada) through a Mitacs Accelerates Internship awarded to Shaiya Robinson, PhD. PMS has received honoraria for CME activities from Nestle Nutrition, Abbott Nutrition, and Mead Johnson Nutrition.

Effect of probiotic administration to breastfeeding mothers with very low birthweight neonates on some neonatal and maternal outcomes: study protocol for a randomised, double-blind, placebo-controlled trial

Preventive effect of prenatal maternal oral probiotic supplementation on neonatal jaundice (POPS Study): A protocol for the randomised double-blind placebo-controlled clinical trial

Beneficial Effects of Probiotic Treatment on Gut Microbiota in Very Low Birth Weight Infants

Effects of probiotics on intestinal microflora in very low birth weight infants on the 14th postnatal day

Efficacy of Probiotics Versus Placebo in the Prevention of Necrotizing Enterocolitis in Preterm Very Low Birth Weight Infants: A Double-Blind Randomized Controlled Trial

Effects of maternal probiotic supplementation on breast milk microbiome and infant gut microbiome and health: a systematic review and meta-analysis of randomized controlled trials

Impact of Clinical Use of Probiotics on Preterm-Related Outcomes in Infants with Extremely Low Birth Weight

[Effects of Probiotics on Feeding Intolerance in Low Birth Weight Premature Infants].

Effect of Oral Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the Vaginal Microbiota, Cytokines and Chemokines in Pregnant Women

Effect of probiotics on vaginal health in pregnancy. EFFPRO, a randomized controlled trial

Benefits of probiotics in preterm neonates in low-income and medium-income countries: a systematic review of randomised controlled trials

Phototherapy with probiotics supplementation therapy and phototherapy alone in neonates with jaundice: A randomized clinical trial

Effect of Probiotic Supplementation on Newborn Birth Weight for Mother with Gestational Diabetes Mellitus or Overweight/Obesity: A Systematic Review and Meta-Analysis

Probiotics, prematurity and neurodevelopment: follow-up of a randomised trial

Probiotics, Prebiotics, and Synbiotics for Prevention of Mortality and Morbidity in Preterm Infants: A Systematic Review and Network Meta-Analysis of Randomized Trials

Effect of probiotic supplementation on the gut microbiota in very preterm infants: a systematic review

Probiotics' effects on gut microbiota in jaundiced neonates: a randomized controlled trial protocol

Oropharyngeal administration of mother’s colostrum, health outcomes of premature infants: study protocol for a randomized controlled trial

Effectiveness of phototherapy with and without probiotics for the treatment of indirect hyperbilirubinaemia in preterm neonates: a randomised controlled trial

Effectiveness of Probiotic, Prebiotic, and Synbiotic Supplementation to Improve Perinatal Mental Health in Mothers: A Systematic Review and Meta-Analysis

Effect of probiotic yoghurt on plasma glucose in overweight and obese pregnant women: a randomized controlled clinical trial